Pharma sector mutual funds have outperformed all other mutual fund categories in the last one year. Pharma mutual funds are topping the return charts with over 58% returns in the last one year. The category has outpaced gold mutual funds which grew by over 37% in the same time period. Pharma funds on an average have grown by over 45% year-to-date.
Pharma sector mutual funds have outperformed all other mutual fund categories in the last one year. Pharma mutual funds are topping the return charts with over 58% returns in the last one year. The category has outpaced gold mutual funds which grew by over 37% in the same time period. Pharma funds on an average have grown by over 45% year-to-date.
The benchmark index for pharma funds, Nifty pharma index grew by 51.5% in the last one year and by 44% since the beginning of this year.
The sector is booming as investors rush towards defensive stocks due to uncertainty caused by the ongoing covid19 pandemic.
The one-year returns of nine pharma sector mutual funds fall between 48% and 70%, shows Value Research. DSP Healthcare Fund generated the highest returns of 69.80% in the last one year.
Mirae Asset Healthcare and ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund followed with 68% and 63% one-year returns respectively.
The category manages assets worth ₹9,035 crore. The largest fund in the category is Nippon India Pharma holding ₹3,496 crore AUM. The scheme gave 61% returns in the last one year.
